195 related articles for article (PubMed ID: 25849941)
1. Transforming growth factor-β pathway activity in glioblastoma.
Frei K; Gramatzki D; Tritschler I; Schroeder JJ; Espinoza L; Rushing EJ; Weller M
Oncotarget; 2015 Mar; 6(8):5963-77. PubMed ID: 25849941
[TBL] [Abstract][Full Text] [Related]
2. Biological Role and Therapeutic Targeting of TGF-β
Seystahl K; Papachristodoulou A; Burghardt I; Schneider H; Hasenbach K; Janicot M; Roth P; Weller M
Mol Cancer Ther; 2017 Jun; 16(6):1177-1186. PubMed ID: 28377490
[TBL] [Abstract][Full Text] [Related]
3. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
[TBL] [Abstract][Full Text] [Related]
4. Differential Expression and Clinical Significance of Transforming Growth Factor-Beta Isoforms in GBM Tumors.
Roy LO; Poirier MB; Fortin D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642484
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
[TBL] [Abstract][Full Text] [Related]
6. The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway.
Silginer M; Burghardt I; Gramatzki D; Bunse L; Leske H; Rushing EJ; Hao N; Platten M; Weller M; Roth P
Oncogene; 2016 Jun; 35(25):3260-71. PubMed ID: 26500056
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
8. Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells.
Gramatzki D; Pantazis G; Schittenhelm J; Tabatabai G; Köhle C; Wick W; Schwarz M; Weller M; Tritschler I
Oncogene; 2009 Jul; 28(28):2593-605. PubMed ID: 19465936
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma differentially regulates TGF-beta1 and TGF-beta2 expression in human retinal pigment epithelial cells through JAK-STAT pathway.
Nagineni CN; Cherukuri KS; Kutty V; Detrick B; Hooks JJ
J Cell Physiol; 2007 Jan; 210(1):192-200. PubMed ID: 17013806
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta isoform expression during bovine ovarian antral follicle development.
Nilsson EE; Doraiswamy V; Skinner MK
Mol Reprod Dev; 2003 Nov; 66(3):237-46. PubMed ID: 14502602
[TBL] [Abstract][Full Text] [Related]
11. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
12. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X
Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
Murakami M; Ikeda T; Saito T; Ogawa K; Nishino Y; Nakaya K; Funaba M
Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
Masi L; Malentacchi C; Campanacci D; Franchi A
Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-beta1 (TGF-beta1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts.
Ylä-Outinen H; Aaltonen V; Björkstrand AS; Hirvonen O; Lakkakorpi J; Vähä-Kreula M; Laato M; Peltonen J
J Invest Dermatol; 1998 Mar; 110(3):232-7. PubMed ID: 9506441
[TBL] [Abstract][Full Text] [Related]
16. NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma.
Wang H; Pan JQ; Luo L; Ning XJ; Ye ZP; Yu Z; Li WS
Mol Cancer; 2015 Feb; 14():2. PubMed ID: 25971746
[TBL] [Abstract][Full Text] [Related]
17. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
[TBL] [Abstract][Full Text] [Related]
18. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.
Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L
Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869
[TBL] [Abstract][Full Text] [Related]
19. Correlation of thrombospondin-1 and transforming growth factor-beta expression with malignancy of glioma.
Kawataki T; Naganuma H; Sasaki A; Yoshikawa H; Tasaka K; Nukui H
Neuropathology; 2000 Sep; 20(3):161-9. PubMed ID: 11132930
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation.
Bossé Y; Thompson C; Stankova J; Rola-Pleszczynski M
Am J Respir Cell Mol Biol; 2006 Jun; 34(6):746-53. PubMed ID: 16439802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]